Tirzepatide
US$ 19.98
before after glp 1 and GLP-1: what the results actually look like Weight Loss Management Solutions |
Description
doi: 10.1177/2167702614521794 60 KlumpKLKeelPKRacineSEBurtAANealeMSiskCLet al
Minimal or no weight loss after 12-16 weeks at a therapeutic maintenance dose (5 mg or higher) should prompt medical evaluation
This should only be done twice
It gets a little complicated, but essentially, BPA/BPS cause changes in a specific microRNA that controls GLP-1 levels
However, clinical trials have only evaluated both drugs within therapeutic dose ranges
Adams, T
